Publicaciones (38) Publicaciones en las que ha participado algún/a investigador/a

2005

  1. A conceptual framework for performance diagnosis and training prescription from submaximal gas exchange parameters - Theory and application

    International Journal of Sports Medicine, Supplement, Vol. 26, Núm. 1

  2. Association of the genetic polymorphisms of the renin-angiotensin system with kidney graft long-term outcome: Preliminary results

    Transplantation Proceedings

  3. Comments of point: Counterpoint "positive effects of intermittent hypoxia (live high:train low) on exercise performance are/are not mediated primarily by augmented red cell volume [3] (multiple letters)

    Journal of Applied Physiology

  4. Comments on Point:Counterpoint "Positive effects of intermittent hypoxia (live high:train low) on exercise performance are/are not mediated primarily by augmented red cell volume".

    Journal of applied physiology (Bethesda, Md. : 1985)

  5. Del conocimiento de la etiología bacteriana al tratamiento y la prevención de las infecciones más prevalentes en la comunidad: Las infecciones odontológicas

    Revista Espanola de Quimioterapia, Vol. 18, Núm. 2, pp. 136-145

  6. Derecho deportivo y derecho administrativo: la internvención administrativa en el deporte

    El derecho deportivo en España: 1975-2005 (Consejería de Turismo, Comercio y Deporte), pp. 81-104

  7. Diseño del plan general de incorporación al espacio europeo de educación superior en la facultad de CAFYD de la Universidad Europea de Madrid

    Kronos: revista universitaria de la actividad física y el deporte, Vol. 4, Núm. 7, pp. 39-45

  8. Does intermittent hypoxia increase erythropoiesis in professional cyclists during a 3-week race?

    Canadian Journal of Applied Physiology, Vol. 30, Núm. 1, pp. 61-73

  9. Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 742-747

  10. Effect of warm-up on cycle time trial performance

    Medicine and Science in Sports and Exercise, Vol. 37, Núm. 9, pp. 1608-1614

  11. El juego entendido como terapia y durante la terapia con adultos

    Boletín informativo de la Asociación Española de Terapeutas formados en el Concepto Bobath ( AETB ), Núm. 15, pp. 17

  12. Entrevista: Adriana Moschini: Tutora Bobath IBITA. Buenos Aires (Argentina)

    Boletín informativo de la Asociación Española de Terapeutas formados en el Concepto Bobath ( AETB ), Núm. 16, pp. 20-21

  13. Farmacodinamia de los betalactámicos y su modificación por el sistema inmunitario

    Revista Espanola de Quimioterapia

  14. Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: Does this mutation impair performance?

    Journal of Applied Physiology, Vol. 98, Núm. 6, pp. 2108-2112

  15. Genotypic versus phenotypic characterization, with respect to susceptibility and identification, of 17 clinical isolates of Staphylococcus lugdunensis

    Journal of Antimicrobial Chemotherapy, Vol. 56, Núm. 2, pp. 287-291

  16. How do endurance runners actually train? Relationship with competition performance

    Medicine and Science in Sports and Exercise, Vol. 37, Núm. 3, pp. 496-504

  17. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point

    International Journal of Antimicrobial Agents, Vol. 25, Núm. 2, pp. 163-167

  18. Intrahospital supervised exercise training: A complementary tool in the therapeutic armamentrium against childhood leukemia

    Leukemia

  19. Is physical fitness decreased in survivors of childhood leukemia? A systematic review

    Leukemia, Vol. 19, Núm. 1, pp. 13-17

  20. Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 2, pp. 209-213